We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.28M
2
ADP icon
Automatic Data Processing
ADP
+$2.29M
3
AMZN icon
Amazon
AMZN
+$1.57M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.47M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.22M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMC icon
1201
Commercial Metals
CMC
$7.63B
$1.26K ﹤0.01%
65
-1
-2% -$19
SAP icon
1202
SAP
SAP
$187B
$1.26K ﹤0.01%
12
– –
TGNA
1203
DELISTED
TEGNA Inc
TGNA
$1.24K ﹤0.01%
86
-48
-36% -$738
ARNA
1204
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.18K ﹤0.01%
70
– –
AIG.WS
1205
DELISTED
American International Group, Inc.
AIG.WS
$1.18K ﹤0.01%
56
-4
-7% -$83
KIE icon
1206
State Street SPDR S&P Insurance ETF
KIE
$619M
$1.15K ﹤0.01%
39
-3
-7% -$86
VNDA icon
1207
Vanda Pharmaceuticals
VNDA
$312M
$1.14K ﹤0.01%
70
– –
FIT
1208
DELISTED
Fitbit, Inc. Class A common stock
FIT
$1.06K ﹤0.01%
200
– –
PLUG icon
1209
Plug Power
PLUG
$2.92B
$1.02K ﹤0.01%
+500
New +$1.05K
BBL
1210
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$1.01K ﹤0.01%
33
-1
-3% -$31
ICPT
1211
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$969 ﹤0.01%
+8
New +$927
COTV
1212
DELISTED
Cotiviti Holdings, Inc.
COTV
$929 ﹤0.01%
+25
New +$982
VSH icon
1213
Vishay Intertechnology
VSH
$5.86B
$925 ﹤0.01%
+56
New +$920
EQNR icon
1214
Equinor
EQNR
$95.9B
$909 ﹤0.01%
55
-1
-2% -$17
UNIT
1215
Uniti Group
UNIT
$2.63B
$905 ﹤0.01%
36
– –
QCP
1216
DELISTED
Quality Care Properties, Inc.
QCP
$879 ﹤0.01%
48
-28
-37% -$503
E icon
1217
ENI
E
$76B
$872 ﹤0.01%
29
-1
-3% -$32
ZYNE
1218
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$849 ﹤0.01%
50
– –
GF
1219
New Germany Fund
GF
$184M
$844 ﹤0.01%
54
– –
INFY icon
1220
Infosys
INFY
$45B
$841 ﹤0.01%
112
– –
BATRA icon
1221
Atlanta Braves Holdings Series A
BATRA
$3.53B
$836 ﹤0.01%
35
-1
-3% -$24
NVRI icon
1222
Enviri
NVRI
$621M
$789 ﹤0.01%
49
-1
-2% -$14
CARS icon
1223
Cars.com
CARS
$641M
$746 ﹤0.01%
+28
New +$754
AMSC icon
1224
American Superconductor
AMSC
$1.48B
$693 ﹤0.01%
150
– –
CCUR
1225
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
$665 ﹤0.01%
100
– –
47 48
49
50 51

Similar funds

PJB
Paul John Balson Marina Del Rey, California $486M AUM 78.12% 1-Year Est. Return
IVA
International Value Advisers $615M AUM 6.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.